A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus

World Journal of Gastroenterology

Volumn 17, Issue 38, 2011, Pages 4321-4333

  Han, Lei ^a   Zhang, Hong Wei ^a   Xie, Jia Xin ^a   Zhang, Qi ^a   Wang, Hong Yang ^a   Cao, Guang Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Efficacy; Hepatitis B virus; Lamivudine; Meta analysis; Mother to child transmission

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ARTICLE; DRUG EFFICACY; HEPATITIS B; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 80955149605     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i38.4321     Document Type: Article

References (44)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 Suppl 1: S1-S3
2. Petrova M, Kamburov V. Breastfeeding and chronic HBV infection: clinical and social implications. World J Gastroenterol 2010; 16: 5042-5046
3. Bai H, Zhang L, Ma L, Dou XG, Feng GH, Zhao GZ. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol 2007; 13: 3625-3630
4. Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004; 10: 437-438
5. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332: 328-336
6. Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 2011; 46: 1-8
7. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, de Gast GC, Fetter WP, Zwijneberg J, Schalm SW. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15: 1624-1630
8. Chotiyaputta W, Lok AS. Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat 2009; 16: 91-93
9. Wen WH, Chen HL, Ni YH, Hsu HY, Kao JH, Hu FC, Chang MH. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization. Hepatology 2011; 53: 429-436
10. Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev 2010; 19: 777-786
11. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009; 29 Suppl 1: 133-139
12. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-297
13. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10: 3215-3217
14. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002; 359: 1488-1489
15. Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 2010; 116: 147-159
16. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412
17. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
19. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989; 8: 141-151
20. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046-1055
21. Zhang YF. The clinical observation of effect of lamivudine on interrupting mother to infant transmission of chronic HBV on 50 mothers [in Chinese]. J Prat Obst Gynecol 2010; 26: 367-368
22. Han Q. Effection of lamivudine treatment on preventing HBV vertical transmission in pregnant women [in Chinese]. J Med Theor Prac 2010; 23: 631-633
23. Han GR, Fang ZX, Zhao W, Wang GJ, Wang CM, Tang X, Yue X. Efficacy and safety of lamivudine treatment on preventing hepatitis B virus vertical transmission in pregnant women [in Chinese]. Chin J Infect Dis 2009; 27: 673-676
24. Su TB, Liu JL. The observation of effect of lamivudine combined with HBIG and HBV vaccine on interrupting mother to infant transmission of chronic HBV [in Chinese]. Chin J Coal Industry Med 2009; 12: 104
25. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103
26. Shi ZJ, Li XM, Yang YB, Ma L. Clinical research on the interruption of mother to child transmission of HBV- a randomized, double-blind, placebo-control study. Unite for Site 6th Annual Global Health Conference. New Haven (CT): Yale University 2009
27. Yang JH. The clinical observation of effect of lamivudine on blocking mother to infant transmission of chronic HBV [in Chinese]. Int Med Health Guid News 2008; 14: 76-78
28. Guo YZ, Li SX, Ge SL, Wang JH. Effect of lamivudine treatment combined with active-passive immunization on interrupting mother to infant transmission of HBV [in Chinese]. Clin Focus 2008; 23: 1730-1731
29. Xiang GJ, Sun JW, Jiang SQ, Hu XB, Qu AL. Evaluation of therapeutic effect in HBV vertical transmission by lamivudine treatment combined with active-passive immunization for pregnant women [in Chinese]. Chin Prac Med 2007; 2: 14-16
30. Feng HF, Zhang SF. Effect on interruption of hepatitis B virus vertical transmission by lamivudine [in Chinese]. J Appl Clin Pediatr 2007; 22: 1019-1020
31. Li WF, Jiang R, Wei Z, Li Y. Clinical effect and safety of lamivudine in interruption of chronic HBV maternal to infant transmission [in Chinese]. Chin Hepatol 2006; 11: 106-107
32. Li G, Du WJ. The observation of therapeutic effect in interrupting HBV vertical transmission by joint treatment [in Chinese]. J Wenzhou Med Coll 2006; 36: 493-495
33. Han ZH, Chen YH, Li LW, Sun XW, Sun YG, Zhao H, Su XS. Effect and safety of preventing HBV vertical transmission by lamivudine treatment [in Chinese]. Chin J Intern Med 2005; 44: 378
34. Shi MF, Li XM, He J, Yang YB, Hou HY, Zhuang YL, Shen HM. Study of Lamivudine in interruption of HBV intrauterine infection [in Chinese]. Clin Med Chin 2005; 21: 77-8
35. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003; 9: 1501-1503
36. Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006; 12: 3434-3437
37. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2: 1099-1102
38. Wang JS, Chen H, Zhu QR. Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol 2005; 11: 3582-3585
39. Zhang SL, Han XB, Yue YF. Relationship between HBV viremia level of pregnant women and intrauterine infection: neated PCR for detection of HBV DNA. World J Gastroenterol 1998; 4: 61-63
40. Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, Shen Q, Xu G, Dong H, Shen J, Zhang J, Han J, Wang L, Liu Y, Wang F, Zhao J, Zhang Q, Ni W, Wang H, Cao G. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol 2011; 106: 81-92
41. Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol 2010; 45: 1063-1071
42. Yin JH, Zhao J, Zhang HW, Xie JX, Li WP, Xu GZ, Shen J, Dong HJ, Zhang J, Wang L, Han JK, Wang HY, Cao GW. HBV genotype C is independently associated with cirrhosis in community-based population. World J Gastroenterol 2010; 16: 379-383
43. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10: 910-912
44. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 2009; 15: 5761-5769